3 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 2, Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow MWN109 2: new trials by email Literature Review of MWN109 2 trials Research Report on MWN109 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity | Phase 3 | Not yet recruiting | Shanghai Minwei Biotechnology Co., Ltd | 760 | 2026-09-01 | 2026-08-21 |
| Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus MWN109 1, MWN109 2, MWN109 3 - Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Recruiting | Shanghai Minwei Biotechnology Co., Ltd | 240 | 2026-06-23 | 2026-09-09 |
| Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity MWN109 1, MWN109 2 - Overweight , Obesity | Phase 2 | Active not recruiting | Shanghai Minwei Biotechnology Co., Ltd | 71 | 2026-03-02 | 2026-09-04 |
| Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity | Phase 2 | Completed | Shanghai Minwei Biotechnology Co., Ltd | 255 | 2026-01-05 | 2026-08-28 |
| Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity | Phase 2 | Active not recruiting | Shanghai Minwei Biotechnology Co., Ltd | 125 | 2025-12-26 | 2026-08-28 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity | Phase 2 | Completed | Shanghai Minwei Biotechnology Co., Ltd | 120 | 2025-08-23 | 2026-08-28 |
| Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity | Phase 1 | Completed | Shanghai Minwei Biotechnology Co., Ltd | 40 | 2025-07-14 | 2026-10-28 |
Obesity (6) · Overweight (6) · Diabetes Mellitus, Type 2 (1)
Shanghai Minwei Biotechnology Co., Ltd (7)
China (7)